Replies to post #2023 on Ocera Therapeutics fka OCRX

[puravida]

Yes indeed Dew however my comment was referring to the elaboration on:

(from PR)
-----(Additional results to be presented today include:

Ammonia reduction correlates with clinical improvement, p=0.0006;
Dose proportional response and pharmacokinetic data indicate some patients were under-dosed;
Earlier timing of drug administration and efficacy assessment is important:
- Patients who improve within 48 hours are discharged earlier than patients who do not improve within 48 hours;
- Patients on OCR-002 are more likely to respond within 48 hours compared to placebo, p=0.026;
Pre-defined measures of improvement were statistically significant: ammonia reduction, p=0.017 and Physician overall evaluation, p= 0.026;
OCR-002 demonstrated improvement in the Model for End-Stage Liver Disease (MELD) scores, p=0.051; and
OCR-002 showed improvement in renal function as measured by the change from baseline in Blood Urea Nitrogen (BUN) levels, p=0.04---)